Announcements

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) on the topic of cancer therapy. The paper list is as follows:

1. “CAR T-Cells for CNS Lymphoma: Driving into New Terrain?”
by Philipp Karschnia, Jens Blobner, Nico Teske, Florian Schöberl, Esther Fitzinger, Martin Dreyling, Joerg-Christian Tonn, Niklas Thon, Marion Subklewe and Louisa von Baumgarten
Cancers 2021, 13(10), 2503; https://doi.org/10.3390/cancers13102503
Available online: https://www.mdpi.com/2072-6694/13/10/2503

2. “Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care?”
by Marco Mazzotta, Laura Pizzuti, Eriseld Krasniqi, Francesca Sofia Di Lisa, Federico Cappuzzo, Lorenza Landi, Domenico Sergi, Fabio Pelle, Sonia Cappelli, Claudio Botti et al.
Cancers 2021, 13(16), 4061; https://doi.org/10.3390/cancers13164061
Available online: https://www.mdpi.com/2072-6694/13/16/4061

3. “Current Knowledge about Mechanisms of Drug Resistance against ALK Inhibitors in Non-Small Cell Lung Cancer”
by Elisabeth Smolle, Valentin Taucher, Joerg Lindenmann, Philipp J. Jost and Martin Pichler
Cancers 2021, 13(4), 699; https://doi.org/10.3390/cancers13040699
Available online: https://www.mdpi.com/2072-6694/13/4/699

4. “Molecular Targeted Therapy in Myelodysplastic Syndromes: New Options for Tailored Treatments”
by Simona Pagliuca, Carmelo Gurnari and Valeria Visconte
Cancers 2022, 13(4), 784; https://doi.org/10.3390/cancers13040784
Available online: https://www.mdpi.com/2072-6694/13/4/784

5. “Targeting CX3CR1 Suppresses the Fanconi Anemia DNA Repair Pathway and Synergizes with Platinum”
by Jemina Lehto, Anna Huguet Ninou, Dimitrios Chioureas, Jos Jonkers and Nina M. S. Gustafsson
Cancers 2021, 13(6), 1442; https://doi.org/10.3390/cancers13061442
Available online: https://www.mdpi.com/2072-6694/13/6/1442

6. “The Agony of Choice—Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond”
by Irene Strassl, Martin Schreder, Normann Steiner, Jakob Rudzki, Hermine Agis, Tina Künz, Nino Müser, Wolfgang Willenbacher, Andreas Petzer, Peter Neumeister et al.
Cancers 2021, 13(18), 4701; https://doi.org/10.3390/cancers13184701
Available online: https://www.mdpi.com/2072-6694/13/18/4701

7. “Challenges of Neoantigen Targeting in Lynch Syndrome and Constitutional Mismatch Repair Deficiency Syndrome”
by Asima Abidi, Mark A. J. Gorris, Evan Brennan, Marjolijn C. J. Jongmans, Dilys D. Weijers, Roland P. Kuiper, Richarda M. de Voer, Nicoline Hoogerbrugge, Gerty Schreibelt and I. Jolanda M. de Vries
Cancers 2021, 13(10), 2345; https://doi.org/10.3390/cancers13102345
Available online: https://www.mdpi.com/2072-6694/13/10/2345

8. “Regulations, Open Data and Healthcare Innovation: A Case of MSK-IMPACT and Its Implications for Better Cancer Care”
by Takaharu Jibiki, Hayato Nishimura, Shintaro Sengoku and Kota Kodama
Cancers 2021, 13(14), 3448; https://doi.org/10.3390/cancers13143448
Available online: https://www.mdpi.com/2072-6694/13/14/3448

9. “Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine”
by Ioannis Chanias, Kristina Stojkov, Gregor Th. Stehle, Michael Daskalakis, Helena Simeunovic, Linet Muthoni Njue, Annatina S. Schnegg-Kaufmann, Naomi A. Porret, Ramanjaneyulu Allam, Tata Nageswara Rao et al.
Cancers 2021, 13(13), 3296; https://doi.org/10.3390/cancers13133296
Available online: https://www.mdpi.com/2072-6694/13/13/3296

10. “Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (¹¹¹In)/Yttrium 90 (⁹⁰Y) Ibritumomab Tiuxetan (Zevalin^®) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose Levels”
by Richard L. Wahl, Eric C. Frey, Heather A. Jacene, Brad S. Kahl, Steven Piantadosi, Jesus A. Bianco, Richard J. Hammes, Miah Jung, Wayne Kasecamp, Bin He et al.
Cancers 2021, 13(11), 2828; https://doi.org/10.3390/cancers13112828
Available online: https://www.mdpi.com/2072-6694/13/11/2828

11. “Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease”
by Chaobo Chen, Hanghang Wu, Hui Ye, Agustín Tortajada, Sandra Rodríguez-Perales, Raúl Torres-Ruiz, August Vidal, Maria Isabel Peligros, Johanna Reissing, Tony Bruns et al.
Cancers 2022, 14(1), 78; https://doi.org/10.3390/cancers14010078
Available online: https://www.mdpi.com/2072-6694/14/1/78

12. “Challenges and Novel Opportunities of Radiation Therapy for Brain Metastases in Non-Small Cell Lung Cancer”
by Paola Anna Jablonska, Joaquim Bosch-Barrera, Diego Serrano, Manuel Valiente, Alfonso Calvo and Javier Aristu
Cancers 2021, 13(9), 2141; https://doi.org/10.3390/cancers13092141
Available online: https://www.mdpi.com/2072-6694/13/9/2141

13. “Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer”
by Arturo Araujo, Leah M. Cook, Jeremy S. Frieling, Winston Tan, John A. Copland II, Manish Kohli, Shilpa Gupta, Jasreman Dhillon, Julio Pow-Sang, Conor C. Lynch et al.
Cancers 2021, 13(14), 677; https://doi.org/10.3390/cancers13040677
Available online: https://www.mdpi.com/2072-6694/13/4/677

14. “Gliomas Infiltrating the Corpus Callosum: A Systematic Review of the Literature”
by Paolo Palmisciano, Gianluca Ferini, Gina Watanabe, Christian Ogasawara, Emal Lesha, Othman Bin-Alamer, Giuseppe E. Umana, Kenny Yu, Aaron A. Cohen-Gadol, Tarek Y. El Ahmadieh et al.
Cancers 2022, 14(10), 2507; https://doi.org/10.3390/cancers14102507
Available online: https://www.mdpi.com/2072-6694/14/10/2507

15. “Defining the Criteria for Reflex Testing for BRAF Mutations in Cutaneous Melanoma Patients”
by Sarah Zhou, Daniel Sikorski, Honghao Xu, Andrei Zubarev, May Chergui, François Lagacé, Wilson H. Miller, Jr., Margaret Redpath, Stephanie Ghazal, Marcus O. Butler et al.
Cancers 2021, 13(9), 2282; https://doi.org/10.3390/cancers13092282
Available online: https://www.mdpi.com/2072-6694/13/9/2282

You can check more information about the Section “Cancer Therapy” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Cancer_Therapy.

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) in the Section “Cancer Informatics and Big Data”. The paper list is as follows:

1. “The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis”
by Jacek Marzec, Helen Ross-Adams, Stefano Pirrò, Jun Wang, Yanan Zhu, Xueying Mao, Emanuela Gadaleta, Amar S. Ahmad, Bernard V. North, Solène-Florence Kammerer-Jacquet et al.
Cancers 2021, 13(2), 345; https://doi.org/10.3390/cancers13020345
Available online: https://www.mdpi.com/2072-6694/13/2/345

2. “Bioinformatic Approaches to Validation and Functional Analysis of 3D Lung Cancer Models”
by P. Jonathan Li, Jeroen P. Roose, David M. Jablons and Johannes R. Kratz
Cancers 2021, 13(4), 701; https://doi.org/10.3390/cancers13040701
Available online: https://www.mdpi.com/2072-6694/13/4/701

3. “Cancers in Agreement? Exploring the Cross-Talk of Cancer Metabolomic and Transcriptomic Landscapes Using Publicly Available Data”
by Derek van Tilborg and Edoardo Saccenti
Cancers 2021, 13(3), 393; https://doi.org/10.3390/cancers13030393
Available online: https://www.mdpi.com/2072-6694/13/3/393

4. “Comprehensively Exploring the Mutational Landscape and Patterns of Genomic Evolution in Hypermutated Cancers”
by Peng-Chan Lin, Yu-Min Yeh, Hui-Ping Hsu, Ren-Hao Chan, Bo-Wen Lin, Po-Chuan Chen, Chien-Chang Pan, Keng-Fu Hsu, Jenn-Ren Hsiao, Yan-Shen Shan et al.
Cancers 2021, 13(17), 4317; https://doi.org/10.3390/cancers13174317
Available online: https://www.mdpi.com/2072-6694/13/17/4317

5. “Epigenomic Analysis of RAD51 ChIP-seq Data Reveals cis-regulatory Elements Associated with Autophagy in Cancer Cell Lines”
by Keunsoo Kang, Yoonjung Choi, Hyeonjin Moon, Chaelin You, Minjin Seo, Geunho Kwon, Jahyun Yun, Boram Beck and Kyuho Kang
Cancers 2021, 13(11), 2547; https://doi.org/10.3390/cancers13112547
Available online: https://www.mdpi.com/2072-6694/13/11/2547

6. “Identifying Cancer Drivers Using DRIVE: A Feature-Based Machine Learning Model for a Pan-Cancer Assessment of Somatic Missense Mutations”
by Ionut Dragomir, Adnan Akbar, John W. Cassidy, Nirmesh Patel, Harry W. Clifford and Gianmarco Contino
Cancers 2021, 13(11), 2779; https://doi.org/10.3390/cancers13112779
Available online: https://www.mdpi.com/2072-6694/13/11/2779

7. “SurvCNN: A Discrete Time-to-Event Cancer Survival Estimation Framework Using Image Representations of Omics Data”
by Yogesh Kalakoti, Shashank Yadav and Durai Sundar
Cancers 2021, 13(13), 3106; https://doi.org/10.3390/cancers13133106
Available online: https://www.mdpi.com/2072-6694/13/13/3106

8. “Gene-Mutation-Based Algorithm for Prediction of Treatment Response in Colorectal Cancer Patients”
by Heather Johnson, Zahra El-Schich, Amjad Ali, Xuhui Zhang, Athanasios Simoulis, Anette Gjörloff Wingren and Jenny L. Persson
Cancers 2022, 14(8), 2045; https://doi.org/10.3390/cancers14082045
Available online: https://www.mdpi.com/2072-6694/14/8/2045

9. “Discovering Digital Tumor Signatures—Using Latent Code Representations to Manipulate and Classify Liver Lesions”
by Jens Kleesiek, Benedikt Kersjes, Kai Ueltzhöffer, Jacob M. Murray, Carsten Rother, Ullrich Köthe and Heinz-Peter Schlemmer
Cancers 2021, 13(13), 3108; https://doi.org/10.3390/cancers13133108
Available online: https://www.mdpi.com/2072-6694/13/13/3108

10. “Predicting Postoperative Complications in Cancer Patients: A Survey Bridging Classical and Machine Learning Contributions to Postsurgical Risk Analysis”
by Gonçalves, Daniel M., Rui Henriques and Rafael S. Costa
Cancers 2021, 13(13), 3217; https://doi.org/10.3390/cancers13133217
Available online: https://www.mdpi.com/2072-6694/13/13/3217

11. “Survival-Critical Genes Associated with Copy Number Alterations in Lung Adenocarcinoma”
by Chinthalapally V. Rao, Chao Xu, Mudassir Farooqui, Yuting Zhang, Adam S. Asch and Hiroshi Y. Yamada
Cancers 2021, 13(11), 2586; https://doi.org/10.3390/cancers13112586
Available online: https://www.mdpi.com/2072-6694/13/11/2586

12. “PPAR-Responsive Elements Enriched with Alu Repeats May Contribute to Distinctive PPARγ–DNMT1 Interactions in the Genome”
by Sharma Amit, Fabian Tobar-Tosse, Tikam Chand Dakal, Hongde Liu, Arijit Biswas, Athira Menon, Anoosha Paruchuri, Panagiotis Katsonis, Olivier Lichtarge, M. Michael Gromiha et al.
Cancers 2021, 13(16), 3993; https://doi.org/10.3390/cancers13163993
Available online: https://www.mdpi.com/2072-6694/13/16/3993

13. “Network-Based Analysis to Identify Drivers of Metastatic Prostate Cancer Using GoNetic”
by Louise de Schaetzen van Brienen, Giles Miclotte, Maarten Larmuseau, Jimmy Van den Eynden and Kathleen Marchal
Cancers 2021, 13(21), 5291; https://doi.org/10.3390/cancers13215291
Available online: https://www.mdpi.com/2072-6694/13/21/5291

14. “Network-Based Integration of Multi-Omics Data Identifies the Determinants of miR-491-5p Effects”
by Matthieu Meryet-Figuiere, Mégane Vernon, Mamy Andrianteranagna, Bernard Lambert, Célia Brochen, Jean-Paul Issartel, Audrey Guttin, Pascal Gauduchon, Emilie Brotin, Florent Dingli et al.
Cancers 2021, 13(16), 3970; https://doi.org/10.3390/cancers13163970
Available online: https://www.mdpi.com/2072-6694/13/16/3970

15. “Prediction of Incident Cancers in the Lifelines Population-Based Cohort”
by Francisco O. Cortés-Ibañez, Sunil Belur Nagaraj, Ludo Cornelissen, Gerjan J. Navis, Bert van der Vegt, Grigory Sidorenkov and Geertruida H. de Bock
Cancers 2021, 13(9), 2133; https://doi.org/10.3390/cancers13092133
Available online: https://www.mdpi.com/2072-6694/13/9/2133

You can check more information about the Section “Cancer Informatics and Big Data” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Cancer_Informatics_Big_Data.

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) on the topic of cancer pathophysiology. The paper list is as follows:

1. “The Prevalence of TET2 Gene Mutations in Patients with BCR-ABL-Negative Myeloproliferative Neoplasms (MPN): A Systematic Review and Meta-Analysis”
by Yuh Cai Chia, Md Asiful Islam, Phil Hider, Peng Yeong Woon, Muhammad Farid Johan, Rosline Hassan and Marini Ramli
Cancers 2021, 13(12), 3078; https://doi.org/10.3390/cancers13123078
Available online: https://www.mdpi.com/2072-6694/13/12/3078

2. “Recent Advances in Implantation-Based Genetic Modeling of Biliary Carcinogenesis in Mice”
by Masashi Izumiya, Shingo Kato and Yoshitaka Hippo
Cancers 2021, 13(10), 2292; https://doi.org/10.3390/cancers13102292
Available online: https://www.mdpi.com/2072-6694/13/10/2292

3. “ECM Remodeling in Squamous Cell Carcinoma of the Aerodigestive Tract: Pathways for Cancer Dissemination and Emerging Biomarkers”
by Albina Fejza, Lucrezia Camicia, Evelina Poletto, Greta Carobolante, Maurizio Mongiat and Eva Andreuzzi
Cancers 2021, 13(11), 2759; https://doi.org/10.3390/cancers13112759
Available online: https://www.mdpi.com/2072-6694/13/11/2759

4. “Pathological Changes in Pancreatic Carcinogenesis: A Review”
by Keiko Yamakawa, Juanjuan Ye, Yuko Nakano-Narusawa and Yoko Matsuda
Cancers 2021, 13(4), 686; https://doi.org/10.3390/cancers13040686
Available online: https://www.mdpi.com/2072-6694/13/4/686

5. “Phosphodiesterase 4D Depletion/Inhibition Exerts Anti-Oncogenic Properties in Hepatocellular Carcinoma”
by Federica Ragusa, Nadia Panera, Silvia Cardarelli, Marco Scarsella, Marzia Bianchi, Stefano Biagioni, Mauro Giorgi, Anna Alisi and Mara Massimi
Cancers 2021, 13(9), 2182; https://doi.org/10.3390/cancers13092182
Available online: https://www.mdpi.com/2072-6694/13/9/2182

6. “Molecular and Clinical Implications of Somatostatin Receptor Profile and Somatostatin Analogues Treatment in Oral Cavity Squamous Cell Carcinoma”
by Alba Sanjuan-Sanjuan, Emilia Alors-Perez, Marina Sanchez-Frías, Alicia Dean-Ferrer, Manuel D. Gahete, Susana Heredero-Jung and Raúl M. Luque
Cancers 2021, 13(19), 4828; https://doi.org/10.3390/cancers13194828
Available online: https://www.mdpi.com/2072-6694/13/19/4828

7. “Familial Occurrence of Adult Granulosa Cell Tumors: Analysis of Whole-Genome Germline Variants”
by Joline F. Roze, Joachim Kutzera, Wouter Koole, Margreet G. E. M. Ausems, Kristi Engelstad, Jurgen M. J. Piek, Cor D. de Kroon, René H. M. Verheijen, Gijs van Haaften, Ronald P. Zweemer et al.
Cancers 2021, 13(10), 2430; https://doi.org/10.3390/cancers13102430
Available online: https://www.mdpi.com/2072-6694/13/10/2430

8. “Prognostic Value of Apoptosis-Inducing Factor (AIF) in Germ Cell Tumors”
by Katarina Letkovska, Pavel Babal, Zuzana Cierna, Silvia Schmidtova, Veronika Liskova, Katarína Kalavska, Vera Miskovska, Samuel Horak, Katarina Rejlekova, Michal Chovanec et al.
Cancers 2021, 13(4), 776; https://doi.org/10.3390/cancers13040776
Available online: https://www.mdpi.com/2072-6694/13/4/776

9. “Bone Marrow Homeostasis Is Impaired via JAK/STAT and Glucocorticoid Signaling in Cancer Cachexia Model”
by Jinyeong Yu, Sanghyuk Choi, Aran Park, Jungbeom Do, Donghyun Nam, Youngjae Kim, Jinok Noh, Kil Yeon Lee, Chi Hoon Maeng and Ki-Sook Park
Cancers 2021, 13(5), 1059; https://doi.org/10.3390/cancers13051059
Available online: https://www.mdpi.com/2072-6694/13/5/1059

10. “Multiple Myeloma Relapse Is Associated with Increased NFκB Pathway Activity and Upregulation of the Pro-Survival BCL-2 Protein BFL-1”
by Ingrid Spaan, Anja van de Stolpe, Reinier A. Raymakers and Victor Peperzak
Cancers 2021, 13(18), 4668; https://doi.org/10.3390/cancers13184668
Available online: https://www.mdpi.com/2072-6694/13/18/4668

11. “APOBEC SBS13 Mutational Signature—A Novel Predictor of Radioactive Iodine Refractory Papillary Thyroid Carcinoma”
by Sarah Siraj, Tariq Masoodi, Abdul K. Siraj, Saud Azam, Zeeshan Qadri, Sandeep K. Parvathareddy, Rong Bu, Khawar S. Siddiqui, Saif S. Al-Sobhi, Mohammed AlDawish et al.
Cancers 2022, 14(6), 1584; https://doi.org/10.3390/cancers14061584
Available online: https://www.mdpi.com/2072-6694/14/6/1584

12. “Glioblastomas within the Subventricular Zone Are Region-Specific Enriched for Mesenchymal Transition Markers: An Intratumoral Gene Expression Analysis”
by Diana J. Z. Dalemans, Sharon Berendsen, Kaspar Draaisma, Pierre A. Robe and Tom J. Snijders
Cancers 2021, 13(15), 3764; https://doi.org/10.3390/cancers13153764
Available online: https://www.mdpi.com/2072-6694/13/15/3764

13. “Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic Modifications”
by Jacqueline Schütt, Theresa Nägler, Tino Schenk and Annamaria Brioli
Cancers 2021, 13(16), 4069; https://doi.org/10.3390/cancers13164069
Available online: https://www.mdpi.com/2072-6694/13/16/4069

14. “MiRNA Deregulation Distinguishes Anaplastic Thyroid Carcinoma (ATC) and Supports Upregulation of Oncogene Expression”
by Danny Misiak, Marcus Bauer, Jana Lange, Jacob Haase, Juliane Braun, Kerstin Lorenz, Claudia Wickenhauser and Stefan Hüttelmaier
Cancers 2021, 13(23), 5913; https://doi.org/10.3390/cancers13235913
Available online: https://www.mdpi.com/2072-6694/13/23/5913

15. “Loss of MAGEC3 Expression Is Associated with Prognosis in Advanced Ovarian Cancers”
by James Ellegate, Jr., Michalis Mastri, Emily Isenhart, John J. Krolewski, Gurkamal Chatta, Eric Kauffman, Melissa Moffitt and Kevin H. Eng
Cancers 2022, 14(3), 731; https://doi.org/10.3390/cancers14030731
Available online: https://www.mdpi.com/2072-6694/14/3/731

You can check more information about the Section “Cancer Pathophysiology” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Cancer_Pathophysiology.

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) on the topic of cancer causes, screening and diagnosis. The paper list is as follows:

1. “Oncologic Imaging of the Lymphatic System: Current Perspective with Multi-Modality Imaging and New Horizon”
by Mohamed Elshikh, Ahmed W Moawad, Usama Salem, Sergio P Klimkowski, Talaat Hassan, Brinda Rao Korivi, Corey T Jensen, Sanaz Javadi and Khaled M Elsayes
Cancers 2021, 13(18), 4554; https://doi.org/10.3390/cancers13184554
Available online: https://www.mdpi.com/2072-6694/13/18/4554

2. “New Markers of Disease Progression in Myelofibrosis”
by Rita Campanelli, Margherita Massa, Vittorio Rosti and Giovanni Barosi
Cancers 2021, 13(21), 5324; https://doi.org/10.3390/cancers13215324
Available online: https://www.mdpi.com/2072-6694/13/21/5324

3. “Mutation of the Cell Cycle Regulator p27kip1 Drives Pseudohypoxic Pheochromocytoma Development”
by Hermine Mohr, Simone Ballke, Nicole Bechmann, Sebastian Gulde, Jaber Malekzadeh-Najafabadi, Mirko Peitzsch, Vasilis Ntziachristos, Katja Steiger, Tobias Wiedemann and Natalia S. Pellegata
Cancers 2021, 13(1), 126; https://doi.org/10.3390/cancers13010126
Available online: https://www.mdpi.com/2072-6694/13/1/126

4. “Recurrent Spliceosome Mutations in Cancer: Mechanisms and Consequences of Aberrant Splice Site Selection”
by Carlos A. Niño, Rossella Scotto di Perrotolo and Simona Polo
Cancers 2022, 14(2), 281; https://doi.org/10.3390/cancers14020281
Available online: https://www.mdpi.com/2072-6694/14/2/281

5. “Epigenetic Priming with Decitabine Augments the Therapeutic Effect of Cisplatin on Triple-Negative Breast Cancer Cells through Induction of Proapoptotic Factor NOXA”
by Wataru Nakajima, Kai Miyazaki, Masahiro Sakaguchi, Yumi Asano, Mariko Ishibashi, Tomoko Kurita, Hiroki Yamaguchi, Hiroyuki Takei and Nobuyuki Tanaka
Cancers 2022, 14(1), 248; https://doi.org/10.3390/cancers14010248
Available online: https://www.mdpi.com/2072-6694/14/1/248

6. “EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 1)”
by Magda Zanelli, Francesca Sanguedolce, Andrea Palicelli, Maurizio Zizzo, Giovanni Martino, Cecilia Caprera, Valentina Fragliasso, Alessandra Soriano, Luca Valle, Stefano Ricci et al.
Cancers 2021, 13(18), 4578; https://doi.org/10.3390/cancers13184578
Available online: https://www.mdpi.com/2072-6694/13/18/4578

7. “Associations between Genetically Predicted Circulating Protein Concentrations and Endometrial Cancer Risk”
by Jingjing Zhu, Tracy A. O’Mara, Duo Liu, Veronica Wendy Setiawan, Dylan Glubb, Amanda B. Spurdle, Peter A. Fasching, Diether Lambrechts, Daniel Buchanan, Pik Fang Kho et al.
Cancers 2021, 13(9), 2088; https://doi.org/10.3390/cancers13092088
Available online: https://www.mdpi.com/2072-6694/13/9/2088

8. “Could Ovarian Cancer Prediction Models Improve the Triage of Symptomatic Women in Primary Care? A Modelling Study Using Routinely Collected Data”
by Garth Funston, Gary Abel, Emma J. Crosbie, Willie Hamilton and Fiona M. Walter
Cancers 2021, 13(12), 2886; https://doi.org/10.3390/cancers13122886
Available online: https://www.mdpi.com/2072-6694/13/12/2886

9. “Uncommon Variants of Mature T-Cell Lymphomas (MTCLs): Imaging and Histopathologic and Clinical Features with Updates from the Fourth Edition of the World Health Organization (WHO) Classification of Lymphoid Neoplasms”
by Ahmed Ebada Salem, Yehia H. Zaki, Gamal El-Hussieny, Khaled I. ElNoueam, Akram M. Shaaban, Bhasker Rao Koppula, Ming Yang, Mohamed Salama, Khaled M. Elsayes and Matthew F. Covington
Cancers 2021, 13(20), 5217; https://doi.org/10.3390/cancers13205217
Available online: https://www.mdpi.com/2072-6694/13/20/5217

10. “Accumulation of Temozolomide-Induced Apoptosis, Senescence and DNA Damage by Metronomic Dose Schedule: A Proof-of-Principle Study with Glioblastoma Cells”
by Lea Beltzig, Björn Stratenwerth and Bernd Kaina
Cancers 2021, 13(24), 6287; https://doi.org/10.3390/cancers13246287
Available online: https://www.mdpi.com/2072-6694/13/24/6287

11. “DNA Methylation in INA, NHLH2, and THBS4 Is Associated with Metastatic Disease in Renal Cell Carcinoma”
by Olga Katzendorn, Inga Peters, Natalia Dubrowinskaja, Joana M. Moog, Christel Reese, Hossein Tezval, Pouriya Faraj Tabrizi, Jörg Hennenlotter, Marcel Lafos, Markus A. Kuczyk et al.
Cancers 2022, 14(1), 39; https://doi.org/10.3390/cancers14010039
Available online: https://www.mdpi.com/2072-6694/14/1/39

12. “Nongaussian Intravoxel Incoherent Motion Diffusion Weighted and Fast Exchange Regime Dynamic Contrast-Enhanced-MRI of Nasopharyngeal Carcinoma: Preliminary Study for Predicting Locoregional Failure”
by Ramesh Paudyal, Linda Chen, Jung Hun Oh, Kaveh Zakeri, Vaios Hatzoglou, C. Jillian Tsai, Nancy Lee and Amita Shukla-Dave
Cancers 2021, 13(5), 1128; https://doi.org/10.3390/cancers13051128
Available online: https://www.mdpi.com/2072-6694/13/5/1128

13. “Associations of Computed Tomography Image-Assessed Adiposity and Skeletal Muscles with Triple-Negative Breast Cancer”
by Livingstone Aduse-Poku, Jiang Bian, Dheeraj R. Gopireddy, Mauricio Hernandez, Chandana Lall, Sara M. Falzarano, Shahla Masood, Ara Jo and Ting-Yuan David Cheng
Cancers 2022, 14(7), 1846; https://doi.org/10.3390/cancers14071846
Available online: https://www.mdpi.com/2072-6694/14/7/1846

14. “Preoperative Detection of Liver Involvement by Right-Sided Adrenocortical Carcinoma Using CT and MRI”
by Alice Kedra, Anthony Dohan, Sébastien Gaujoux, Mathilde Sibony, Anne Jouinot, Guillaume Assié, Lionel Groussin Rouiller, Rossella Libé, Jérôme Bertherat, Philippe Soyer et al.
Cancers 2021, 13(7), 1603; https://doi.org/10.3390/cancers13071603
Available online: https://www.mdpi.com/2072-6694/13/7/1603

15. “CT Simplified Radiomic Approach to Assess the Metastatic Ductal Adenocarcinoma of the Pancreas”
by Mirko D’Onofrio, Riccardo De Robertis, Gregorio Aluffi, Camilla Cadore, Alessandro Beleù, Nicolò Cardobi, Giuseppe Malleo, Erminia Manfrin and Claudio Bassi
Cancers 2021, 13(8), 1843; https://doi.org/10.3390/cancers13081843
Available online: https://www.mdpi.com/2072-6694/13/8/1843

You can check more information about the Section “Cancer Causes, Screening and Diagnosis” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Cancer_Causes_Screening_Diagnosis.

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) on the topic of pediatric oncology. The paper list is as follows:

1. “The New Treatment Methods for Non-Hodgkin Lymphoma in Pediatric Patients”
by Justyna Derebas, Kinga Panuciak, Mikołaj Margas, Joanna Zawitkowska and Monika Lejman
Cancers 2022, 14(6), 1569; https://doi.org/10.3390/cancers14061569
Available online: https://www.mdpi.com/2072-6694/14/6/1569

2. “PPM1D Is a Therapeutic Target in Childhood Neural Tumors”
by Jelena Milosevic, Diana Treis, Susanne Fransson, Gabriel Gallo-Oller, Baldur Sveinbjörnsson, Nina Eissler, Keiji Tanino, Kazuyasu Sakaguchi, Tommy Martinsson, Malin Wickström et al.
Cancers 2021, 13(23), 6042; https://doi.org/10.3390/cancers13236042
Available online: https://www.mdpi.com/2072-6694/13/23/6042

3. “Atypical Teratoid Rhabdoid Tumours Are Susceptible to Panobinostat-Mediated Differentiation Therapy”
by Wai C. Chong, W. Samantha N. Jayasekara, Vijesh G. Vaghjiani, Sarah Parackal, Claire Sun, Dean Popovski, Elizabeth M. Algar, Ron Firestein, Paul J. Wood, Sara Khan et al.
Cancers 2021, 13(20), 5145; https://doi.org/10.3390/cancers13205145
Available online: https://www.mdpi.com/2072-6694/13/20/5145

4. “Prevalence of Sleep Disorders, Risk Factors and Sleep Treatment Needs of Adolescents and Young Adult Childhood Cancer Patients in Follow-Up after Treatment”
by Shosha H. M. Peersmann, Martha A. Grootenhuis, Annemieke van Straten, Gerard A. Kerkhof, Wim J. E. Tissing, Floor Abbink, Andrica C. H. de Vries, Jacqueline Loonen, Leontien C. M. Kremer, Gertjan J. L. Kaspers et al.
Cancers 2022, 14(4), 926; https://doi.org/10.3390/cancers14040926
Available online: https://www.mdpi.com/2072-6694/14/4/926

5. “Parental Sleep, Distress, and Quality of Life in Childhood Acute Lymphoblastic Leukemia: A Longitudinal Report from Diagnosis up to Three Years Later”
by Niki Rensen, Lindsay Steur, Martha Grootenhuis, Jos Twisk, Natasha van Eijkelenburg, Inge van der Sluis, Natasja Dors, Cor van den Bos, Wim Tissing, Gertjan Kaspers et al.
Cancers 2022, 14(11), 2779; https://doi.org/10.3390/cancers14112779
Available online: https://www.mdpi.com/2072-6694/14/11/2779

6. “Maternal Thyroid Disease and the Risk of Childhood Cancer in the Offspring”
by Laura K. Seppälä, Laura-Maria Madanat-Harjuoja, Maarit K. Leinonen, Mitja Lääperi and Kim Vettenranta
Cancers 2021, 13(21), 5409; https://doi.org/10.3390/cancers13215409
Available online: https://www.mdpi.com/2072-6694/13/21/5409

7. “Natural History of Untreated Retinoblastoma”
by Junyang Zhao, Zhaoxun Feng and Brenda L. Gallie
Cancers 2021, 13(15), 3646; https://doi.org/10.3390/cancers13153646
Available online: https://www.mdpi.com/2072-6694/13/15/3646

8. “Concordance of Child Self-Reported and Parent Proxy-Reported Posttraumatic Growth in Childhood Cancer Survivors”
by Veronika Koutná, Marek Blatný and Martin Jelínek
Cancers 2021, 13(16), 4230; https://doi.org/10.3390/cancers13164230
Available online: https://www.mdpi.com/2072-6694/13/16/4230

9. “MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment”
by Damiano Bartolucci, Luca Montemurro, Salvatore Raieli, Silvia Lampis, Andrea Pession, Patrizia Hrelia and Roberto Tonelli
Cancers 2022, 14(18), 4421; https://doi.org/10.3390/cancers14184421
Available online: https://www.mdpi.com/2072-6694/14/18/4421

10. “Increased Replication Stress Determines ATR Inhibitor Sensitivity in Neuroblastoma Cells”
by David King, Harriet E. D. Southgate, Saskia Roetschke, Polly Gravells, Leona Fields, Jessica B. Watson, Lindi Chen, Devon Chapman, Daniel Harrison, Daniel Yeomanson et al.
Cancers 2021, 13(24), 6215; https://doi.org/10.3390/cancers13246215
Available online: https://www.mdpi.com/2072-6694/13/24/6215

11. “Adrenocortical Carcinoma in Childhood: A Systematic Review”
by Maria Riedmeier, Boris Decarolis, Imme Haubitz, Sophie Müller, Konstantin Uttinger, Kevin Börner, Joachim Reibetanz, Armin Wiegering, Christoph Härtel, Paul-Gerhardt Schlegel et al.
Cancers 2021, 13(21), 5266; https://doi.org/10.3390/cancers13215266
Available online: https://www.mdpi.com/2072-6694/13/21/5266

12. “Osteopathic Treatment and Evaluation in the Clinical Setting of Childhood Hematological Malignancies”
by Monica Barbieri, William Zardo, Chiara Frittoli, Clara Rivolta, Valeria Valdata, Federico Bouquin, Greta Passignani, Alberto Maggiani, Momcilo Jankovic, Andrea Cossio et al.
Cancers 2021, 13(24), 6321; https://doi.org/10.3390/cancers13246321
Available online: https://www.mdpi.com/2072-6694/13/24/6321

13. “The Impact of a Precision-Based Exercise Intervention in Childhood Hematological Malignancies Evaluated by an Adapted Yo-Yo Intermittent Recovery Test”
by William Zardo, Emanuele Villa, Eleonora Corti, Tommaso Moriggi, Giorgia Radaelli, Alessandra Ferri, Mauro Marzorati, Cristiano Eirale, Paola Vago, Andrea Biondi et al.
Cancers 2022, 14(5), 1187; https://doi.org/10.3390/cancers14051187
Available online: https://www.mdpi.com/2072-6694/14/5/1187

14. “Identification of Biochemical and Molecular Markers of Early Aging in Childhood Cancer Survivors”
by Silvia Ravera, Tiziana Vigliarolo, Silvia Bruno, Fabio Morandi, Danilo Marimpietri, Federica Sabatini, Monica Dagnino, Andrea Petretto, Martina Bartolucci, Monica Muraca et al.
Cancers 2021, 13(20), 5214; https://doi.org/10.3390/cancers13205214
Available online: https://www.mdpi.com/2072-6694/13/20/5214

15. “Pleuropneumonectomy as Salvage Therapy in Children Suffering from Primary or Metastatic Sarcomas with Pleural Localizations”
by Frédéric Hameury, Perrine Marec-Berard, Mathilde Eymery, Marc H. W. Wijnen, Niels van der Kaaij, Pierre-Yves Mure, François Tronc, Franck Chotel, Clara Libbrecht, Wim Jan P. van Boven et al.
Cancers 2021, 13(15), 3655; https://doi.org/10.3390/cancers13153655
Available online: https://www.mdpi.com/2072-6694/13/15/3655

You can check more information about the Section “Pediatric Oncology” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Pediatric_Oncology.

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) on the topic of infectious agents and cancer. The paper list is as follows:

1. “Primaquine as a Candidate for HHV-8-Associated Primary Effusion Lymphoma and Kaposi’s Sarcoma Treatment”
by Adélie Gothland, Valentin Leducq, Philippe Grange, Ousmane Faye, Laurianne Beauvais Remigereau, Sophie Sayon, Nathalie Désiré, Aude Jary, Emmanuel Laplantine, Almoustapha Issiaka Maiga et al.
Cancers 2022, 14(3), 543; https://doi.org/10.3390/cancers14030543
Available online: https://www.mdpi.com/2072-6694/14/3/543

2. “Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis of Clinical Trial Demographics”
by Tamar M. Gordis, Joshua L. Cagle, Shaun A. Nguyen and Jason G. Newman
Cancers 2022, 14(16), 4061; https://doi.org/10.3390/cancers14164061
Available online: https://www.mdpi.com/2072-6694/14/16/4061

3. “Microbe-Mediated Activation of Toll-like Receptor 2 Drives PDL1 Expression in HNSCC”
by Jacqueline E Mann, Megan L Ludwig, Aditi Kulkarni, Erin B Scheftz, Isabel R Murray, Jingyi Zhai, Elizabeth Gensterblum-Miller, Hui Jiang and J Chad Brenner
Cancers 2021, 13(19), 4782; https://doi.org/10.3390/cancers13194782
Available online: https://www.mdpi.com/2072-6694/13/19/4782

4. “Diagnostic Utility of Bronchoalveolar Lavage in Patients with Acute Leukemia under Broad-Spectrum Anti-Infective Treatment”
by Susanne Ghandili, Philipp H. von Kroge, Marcel Simon, Frank O. Henes, Holger Rohde, Armin Hoffmann, Nick Benjamin Lindeman, Carsten Bokemeyer, Walter Fiedler and Franziska Modemann
Cancers 2022, 14(11), 2773; https://doi.org/10.3390/cancers14112773
Available online: https://www.mdpi.com/2072-6694/14/11/2773

5. “Dysregulation of Liver Regeneration by Hepatitis B Virus Infection: Impact on Development of Hepatocellular Carcinoma”
by Eun-Sook Park, Mehrangiz Dezhbord, Ah Ram Lee, Bo Bae Park and Kyun-Hwan Kim
Cancers 2022, 14(15), 3566; https://doi.org/10.3390/cancers14153566
Available online: https://www.mdpi.com/2072-6694/14/15/3566

6. “Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma of the Tonsil versus Base of Tongue: A Systematic Review and Meta-Analysis”
by Nicolas S. Poupore, Tiffany Chen, Shaun A. Nguyen, Cherie-Ann O. Nathan and Jason G. Newman
Cancers 2022, 14(15), 3837; https://doi.org/10.3390/cancers14153837
Available online: https://www.mdpi.com/2072-6694/14/15/3837

7. “Interaction of HPV16 and Cutaneous HPV in Head and Neck Cancer”
by Walid A. Al-Soneidar, Sam Harper, Babatunde Y. Alli and Belinda Nicolau
Cancers 2022, 14(21), 5197; https://doi.org/10.3390/cancers14215197
Available online: https://www.mdpi.com/2072-6694/14/21/5197

8. “The Role of Bacteria in KSHV Infection and KSHV-Induced Cancers”
by Ashley Markazi, Wen Meng, Paige M. Bracci, Michael S. McGrath and Shou-Jiang Gao
Cancers 2021, 13(17), 4269; https://doi.org/10.3390/cancers13174269
Available online: https://www.mdpi.com/2072-6694/13/17/4269

9. “DNA and mRNA Vaccines for Chronic Viral Infections and Cancer: Rationale, Mechanisms, and Progress”
by Margaret A. Liu
Cancers 2022, 14(23), 5874; https://doi.org/10.3390/cancers14235874
Available online: https://www.mdpi.com/2072-6694/14/23/5874

10. “HPV Infection Leaves a DNA Methylation Signature in Oropharyngeal Cancer Affecting Both Coding Genes and Transposable Elements”
by Diego Camuzi, Luisa Aguirre Buexm, Simone de Queiroz Chaves Lourenço, Davide Degli Esposti, Cyrille Cuenin, Monique de Souza Almeida Lopes, Francesca Manara, Fazlur Rahman Talukdar, Zdenko Herceg, Luis Felipe Ribeiro Pinto et al.
Cancers 2021, 13(14), 3621; https://doi.org/10.3390/cancers13143621
Available online: https://www.mdpi.com/2072-6694/13/14/3621

11. “Patient-Reported Outcomes in Cancer Patients with HIV”
by Anna E. Coghill, Naomi C. Brownstein, Sweta Sinha, Zachary J. Thompson, Brittney L. Dickey, Aasha I. Hoogland, Peter A. Johnstone, Gita Suneja and Heather S. Jim
Cancers 2022, 14(23), 5889; https://doi.org/10.3390/cancers14235889
Available online: https://www.mdpi.com/2072-6694/14/23/5889

12. “Clinical Outcomes in COVID-19 Patients Treated with Immunotherapy”
by Haris Hatic, Kristine R. Hearld, Devika Das and Jessy Deshane
Cancers 2022, 14(23), 5954; https://doi.org/10.3390/cancers14235954
Available online: https://www.mdpi.com/2072-6694/14/23/5954

13. “Aberrant Methylation of Somatostatin Receptor 2 Gene Is Initiated in Aged Gastric Mucosa Infected with Helicobacter pylori and Consequential Gene Silencing Is Associated with Establishment of Inflammatory Microenvironment In Vitro Study”
by Hee-Jin Kim, Jong-Lyul Park, Byoung-Ha Yoon, Keeok Haam, Haejeong Heo, Jong-Hwan Kim, Seon-Young Kim, Mirang Kim, Woo-Ho Kim, Sang-Il Lee et al.
Cancers 2022, 14(24), 6183; https://doi.org/10.3390/cancers14246183
Available online: https://www.mdpi.com/2072-6694/14/24/6183

14. “Effects of Human Papilloma Virus E6/E7 Oncoproteins on Genomic Structure in Head and Neck Squamous Cell Carcinoma”
by Matthew Uzelac, Armon Barakchi, Varsha Beldona, Daniel John, Jaideep Chakladar, Wei Tse Li and Weg M. Ongkeko
Cancers 2022, 14(24), 6190; https://doi.org/10.3390/cancers14246190
Available online: https://www.mdpi.com/2072-6694/14/24/6190

15. “HIV-1 Protease as DNA Immunogen against Drug Resistance in HIV-1 Infection: DNA Immunization with Drug Resistant HIV-1 Protease Protects Mice from Challenge with Protease-Expressing Cells”
by Stefan Petkov, Athina Kilpeläinen, Ekaterina Bayurova, Anastasia Latanova, Dzeina Mezale, Ilse Fridrihsone, Elizaveta Starodubova, Juris Jansons, Alesja Dudorova, Ilya Gordeychuk et al.
Cancers 2023, 15(1), 238; https://doi.org/10.3390/cancers15010238
Available online: https://www.mdpi.com/2072-6694/15/1/238

You can check more information about the Section “Infectious Agents and Cancer” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Infectious_Agents_Cancer.

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) on the topic of transplant oncology and cancer nursing care. The paper list is as follows:

1. “Emulation of a Target Trial to Evaluate the Causal Effect of Palliative Care Consultation on the Survival Time of Patients with Hepatocellular Carcinoma”
by Tassaya Buranupakorn, Phaviga Thangsuk, Jayanton Patumanond and Phichayut Phinyo
Cancers 2021, 13(5), 992; https://doi.org/10.3390/cancers13050992
Available online: https://www.mdpi.com/2072-6694/13/5/992

2. “Cost-Effectiveness of Nutrient Supplementation in Cancer Survivors”
by Amy L. Shaver, Theresa A. Tufuor, Jing Nie, Shauna Ekimura, Keri Marshall, Susan Hazels Mitmesser and Katia Noyes
Cancers 2021, 13(24), 6276; https://doi.org/10.3390/cancers13246276
Available online: https://www.mdpi.com/2072-6694/13/24/6276

3. “Colorectal Cancer Anatomical Site and Sleep Quality”
by Mimi Ton, Nathaniel F. Watson, Arthur Sillah, Rachel C. Malen, Julia D. Labadie, Adriana M. Reedy, Stacey A. Cohen, Andrea N. Burnett-Hartman, Polly A. Newcomb and Amanda I. Phipps
Cancers 2021, 13(11), 2578; https://doi.org/10.3390/cancers13112578
Available online: https://www.mdpi.com/2072-6694/13/11/2578

4. “The Role of Prehabilitation in Modern Esophagogastric Cancer Surgery: A Comprehensive Review”
by Augustinas Bausys, Morta Mazeikaite, Klaudija Bickaite, Bernardas Bausys, Rimantas Bausys and Kestutis Strupas
Cancers 2022, 14(9), 2096; https://doi.org/10.3390/cancers14092096
Available online: https://www.mdpi.com/2072-6694/14/9/2096

5. “Can National Tests from the Last Year of Compulsory School Be Used to Obtain More Detailed Information about Academic Performance in Children Treated for Brain Tumours? A Nationwide, Population-Based Study from Sweden”
by Malin Lönnerblad, Eva Berglund, Ingrid van’t Hooft and Klas Blomgren
Cancers 2021, 13(1), 135; https://doi.org/10.3390/cancers13010135
Available online: https://www.mdpi.com/2072-6694/13/1/135

6. “Using Process Indicators to Monitor Documentation of Patient-Centred Variables in an Integrated Oncology and Palliative Care Pathway—Results from a Cluster Randomized Trial”
by Marianne Jensen Hjermstad, Julian Hamfjord, Nina Aass, Olav Dajani, Tonje Lundeby, Torunn Wester and Stein Kaasa
Cancers 2021, 13(9), 2194; https://doi.org/10.3390/cancers13092194
Available online: https://www.mdpi.com/2072-6694/13/9/2194

7. “Can the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer?”
by Nicole Tubiana-Mathieu, Thibault Cornette, Stephane Mandigout, Sophie Leobon, François Vincent, Laurence Venat and Elise Deluche
Cancers 2021, 13(22), 5851; https://doi.org/10.3390/cancers13225851
Available online: https://www.mdpi.com/2072-6694/13/22/5851

8. “Identification of Lifestyle Behaviors Associated with Recurrence and Survival in Colorectal Cancer Patients Using Random Survival Forests”
by Moniek van Zutphen, Fränzel J. B. van Duijnhoven, Evertine Wesselink, Ruud W. M. Schrauwen, Ewout A. Kouwenhoven, Henk K. van Halteren, Johannes H. W. de Wilt, Renate M. Winkels, Dieuwertje E. Kok and Hendriek C. Boshuizen
Cancers 2021, 13(10), 2442; https://doi.org/10.3390/cancers13102442
Available online: https://www.mdpi.com/2072-6694/13/10/2442

9. “Medi-Cinema: A Pilot Study on Cinematherapy and Cancer as A New Psychological Approach on 30 Gynecological Oncological Patients”
by Daniela Pia Rosaria Chieffo, Letizia Lafuenti, Ludovica Mastrilli, Rebecca De Paola, Sofia Vannuccini, Marina Morra, Fulvia Salvi, Ivo Boškoski, Vanda Salutari, Gabriella Ferrandina, et al.
Cancers 2022, 14(13), 3067; https://doi.org/10.3390/cancers14133067
Available online: https://www.mdpi.com/2072-6694/14/13/3067

10. “Risk of Pharmacological or Hospital Treatment for Depression in Patients with Colorectal Cancer–Associations with Pre-Cancer Lifestyle, Comorbidity and Clinical Factors”
by Trille Kristina Kjaer, Ida Rask Moustsen-Helms, Vanna Albieri, Signe Benzon Larsen, Thea Helene Degett, Anne Tjønneland, Christoffer Johansen, Susanne K. Kjaer, Ismail Gogenur and Susanne Oksbjerg Dalton
Cancers 2021, 13(8), 1979; https://doi.org/10.3390/cancers13081979
Available online: https://www.mdpi.com/2072-6694/13/8/1979

11. “Maintaining Weight Loss in Obese Men with Prostate Cancer Following a Supervised Exercise and Nutrition Program—A Pilot Study”
by Rebekah L. Wilson, Dennis R. Taaffe, Robert U. Newton, Nicolas H. Hart, Philippa Lyons-Wall and Daniel A. Galvão
Cancers 2021, 13(14), 3411; https://doi.org/10.3390/cancers13143411
Available online: https://www.mdpi.com/2072-6694/13/14/3411

12. ““It’s Always Been a Second Class Cancer”: An Exploration of the Experiences and Journeys of Bereaved Family Carers of People with Sarcoma”
by Moira O’Connor, Greta Smith, Ashleigh Pantaleo, Darren Haywood, Rhys Weaver and Georgia Kb Halkett
Cancers 2021, 13(11), 2670; https://doi.org/10.3390/cancers13112670
Available online: https://www.mdpi.com/2072-6694/13/11/2670

13. “Intra- and Interobserver Variability of Shear Wave Elastography in Rectal Cancer”
by Martina Kastrup Loft, Malene Roland Vils Pedersen, Peter Grimm, Andreas Hoffmann Lauritzen, Claus Dam and Søren Rafael Rafaelsen
Cancers 2022, 14(11), 2633; https://doi.org/10.3390/cancers14112633
Available online: https://www.mdpi.com/2072-6694/14/11/2633

14. “The Extent of Necrosis in Brain Metastases May Predict Subtypes of Primary Cancer and Overall Survival in Patients Receiving Craniotomy”
by Jihwan Yoo, Yoon Jin Cha, Hun Ho Park, Mina Park, Bio Joo, Sang Hyun Suh and Sung Jun Ahn
Cancers 2022, 14(7), 1694; https://doi.org/10.3390/cancers14071694
Available online: https://www.mdpi.com/2072-6694/14/7/1694

15. “The Cost of Enfortumab Vedotin Wastage Due to Vial Size—A Real-World Analysis”
by Michal Sarfaty, Assaf Moore, Ashley M. Regazzi, Aaron P. Mitchell and Jonathan E. Rosenberg
Cancers 2021, 13(23), 5977; https://doi.org/10.3390/cancers13235977
Available online: https://www.mdpi.com/2072-6694/13/23/5977

You can check more information about the Section “Transplant Oncology and Cancer Nursing Care” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Cancer_Nursing_Care.

We are delighted to share some highly cited papers on anti-cancer research that were published in the journal Cancers (ISSN: 2072-6694) in 2021 and 2022. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues which we believe will be of interest to you.

“Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives”
by Robert Jenke, Nina Reßing, Finn K. Hansen, Achim Aigner and Thomas Büch
Cancers 2021, 13(4), 634; https://doi.org/10.3390/cancers13040634
Available online: https://www.mdpi.com/2072-6694/13/4/634

“3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs”
by Mélanie A. G. Barbosa, Cristina P. R. Xavier, Rúben F. Pereira, Vilma Petrikaitė and M. Helena Vasconcelos
Cancers 2022, 14(1), 190; https://doi.org/10.3390/cancers14010190
Available online: https://www.mdpi.com/2072-6694/14/1/190

“Is Emodin with Anticancer Effects Completely Innocent? Two Sides of the Coin”
by Esra Küpeli Akkol, Iffet Irem Tatlı, Gökçe Şeker Karatoprak, Osman Tuncay Ağar, Çiğdem Yücel, Eduardo Sobarzo-Sánchez and Raffaele Capasso
Cancers 2021, 13(11), 2733; https://doi.org/10.3390/cancers13112733
Available online: https://www.mdpi.com/2072-6694/13/11/2733

“Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update”
by Jen-Fu Hsu, Shih-Ming Chu, Chen-Chu Liao, Chao-Jan Wang, Yi-Shan Wang, Mei-Yin Lai, Hsiao-Chin Wang, Hsuan-Rong Huang and Ming-Horng Tsai
Cancers 2021, 13(2), 195; https://doi.org/10.3390/cancers13020195
Available online: https://www.mdpi.com/2072-6694/13/2/195

“Therapeutic Potential of Certain Terpenoids as Anticancer Agents: A Scoping Review”
by Sareh Kamran, Ajantha Sinniah, Mahfoudh A. M. Abdulghani and Mohammed Abdullah Alshawsh
Cancers 2022, 14(5), 1100; https://doi.org/10.3390/cancers14051100
Available online: https://www.mdpi.com/2072-6694/14/5/1100

“The Role of Bruton’s Kinase Inhibitors in Chronic Lymphocytic Leukemia: Current Status and Future Directions”
by Tadeusz Robak, Magda Witkowska and Piotr Smolewski
Cancers 2022, 14(3), 771; https://doi.org/10.3390/cancers14030771
Available online: https://www.mdpi.com/2072-6694/14/3/771

“The Renaissance of Cyclin Dependent Kinase Inhibitors”
by Tobias Ettl, Daniela Schulz and Richard Josef Bauer
Cancers 2022, 14(2), 293; https://doi.org/10.3390/cancers14020293
Available online: https://www.mdpi.com/2072-6694/14/2/293

We hope this announcement will provide useful information for this field.

The low coverage of testing and treatment is the most important gap to be addressed to achieve the global elimination goals of hepatitis B virus (HBV) by 2030. 

To commemorate the World Hepatitis Day 2023, MDPI is launching a special webinar to encourage researchers to come together, take action, and highlight how the exchange of findings facilitates efforts to raise awareness of hepatitis.

We are looking forward to seeing you at the MDPI World Hepatitis Day Webinar 2023. 

Conference secretariat: Ms. Shun Li
Date and time: 28 July 2023, 7:00 a.m. and 3:00 p.m., CEST

This is a free webinar. After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized. 

Unable to attend? Register anyway and we will let you know when the recording is available to watch. 

Session 1:

Register for Session 1 for free!

Session 2:

Register for Session 2 for free! 

Relevant Special Issues:
Pathogens
"Research on Hepatitis B Virus: Past, Present, and Future"
Edited by: Hyung Joon Yim
Submission deadline: 31 August 2023 

JPM
"Novel Challenges and Therapeutic Options for Liver Diseases"
Edited by: Guido Gerken
Submission deadline: 30 September 2023 

Medicina
"Viral Hepatitis Research: Updates and Challenges"
Edited by: Endrit Shahini, Antonio Giovanni Solimando and Antonella Argentiero
Submission deadline: 15 October 2023 

Cells
"Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis: Molecular and Multicellular Control of Evolving Diseased States"
Edited by: Jérôme Eeckhoute
Submission deadline: 15 February 2024 

Diagnostics
"Diagnosis and Management of Liver Diseases—2nd Edition"
Edited by: Jeong-Ju Yoo
Submission deadline: 30 September 2023 

Vaccines
"Vaccination and Treatments against Viral Hepatitis: Achievements, Challenges and Perspectives"
Edited by: Bárbara Vieira Do Lago and Vinicius M. Mello
Submission deadline: 15 October 2023